Biond Biologics Ltd., a private biopharmaceutical company, has entered into a partnership with Merck KGaA, Darmstadt, Germany, to support a Phase 1 clinical trial aimed at treating patients with unresectable or metastatic solid tumors. This clinical trial, designated as BND-35-001 (NCT06274437),
The intricate relationship between the human microbiome and genetics is garnering significant attention in the scientific community. This interplay is not just about understanding our inner microbial world but also about how these microorganisms influence our genetic makeup and overall health. The
In an era when speed, accuracy, and efficiency are critical, the biopharma industry stands on the verge of a huge transformation. Artificial intelligence (AI) is moving beyond just a mere buzzword; it is fast becoming an important factor in how drugs are discovered, developed, and marketed. The
The bioprocessing industry has undergone a rapid series of ebbs and flows over the past few years. Once riding high on a wave of growth driven by the urgent demands of the COVID-19 pandemic, the industry has recently experienced a marked downturn. The question on everyone’s mind is: Is the recovery
Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) specializing in biopharmaceuticals and advanced therapy medicinal products (ATMPs), has taken a monumental step towards bolstering its operational capabilities. The German-based company has announced its
Vertex Pharmaceuticals is on the brink of introducing suzetrigine, a cutting-edge non-opioid painkiller that has showcased promising results in recent phase 3 clinical trials. As the battle against opioid addiction and abuse intensifies, the advent of suzetrigine brings hope for a safer approach to
The launch of the Planova FG1 by Asahi Kasei Medical marks a pivotal advancement in virus removal technology within the bioprocessing industry. This next-generation virus removal filter is designed to enhance efficiency and safety in the production of biotherapeutics, including biopharmaceuticals
Quantum BioPharma Ltd., a biotech firm specializing in neurodegenerative and metabolic disorders, has recently taken legal action against CIBC World Markets and RBC Dominion Securities. The lawsuit, filed in the United States District Court for the Southern District of New York, claims that these
Gilead Sciences recently announced its decision to withdraw Trodelvy from the market as a treatment for bladder cancer, following disappointing results from its confirmatory TROPiCS-04 clinical trial. This marks a notable shift for a drug that initially showed promise in shrinking tumors and
Sage Therapeutics, a biopharmaceutical company specializing in brain health medications, finds itself at a pivotal moment. Facing financial strains and developmental hurdles, the company is taking significant steps to realign its strategy, including layoffs, leadership changes, and focusing on
